Impact of metformin on metastases in patients with breast cancer and type 2 diabetes

Journal of Diabetes and its Complications

Volumn 30, Issue 6, 2016, Pages 1056-1059

  Jacob, Louis ^a   Kostev, Karel ^b   Rathmann, Wolfgang ^c   Kalder, Matthias ^d  

^a UNIVERSITÉ DE LYON   (France)

^b IQVIA   (United States)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Breast cancer; Diabetes; Germany; Metastasis; Metformin

Indexed keywords

HEMOGLOBIN A1C; INCRETIN; INSULIN DERIVATIVE; METFORMIN; SULFONYLUREA; ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; BODY MASS; BREAST CANCER; CANCER PATIENT; CANCER RISK; DIABETIC PATIENT; DRUG SAFETY; FEMALE; FOLLOW UP; GERMANY; HEALTH CARE PRACTICE; HUMAN; ICD-10; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PRESCRIPTION; PRIORITY JOURNAL; PRIVATE HEALTH INSURANCE; BREAST TUMOR; METASTASIS; MIDDLE AGED; PATHOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DIABETES MELLITUS, TYPE 2; FEMALE; GERMANY; HUMANS; HYPOGLYCEMIC AGENTS; METFORMIN; MIDDLE AGED; NEOPLASM METASTASIS;

EID: 84964664260     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2016.04.003     Document Type: Article

References (22)

1. Azoulay, L., Filion, K.B., Platt, R.W., Dahl, M., Dormuth, C.R., Clemens, K.K.,.. Ernst, P., Canadian Network for Observational Drug Effect Studies (CNODES) Investigators. Incretin based drugs and the risk of pancreatic cancer: International multicentre cohort study. BMJ, 352, 2016, i581.
2. Bayraktar, S., Hernadez-Aya, L.F., Lei, X., Meric-Bernstam, F., Litton, J.K., Hsu, L.,.. Gonzalez-Angulo, A.M., Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer. Cancer 118 (2012), 1202–1211, 10.1002/cncr.26439 (PMID:21800293).
3. Becher, H., Kostev, K., Schröder-Bernhardi, D., Validity and representativeness of the “Disease Analyzer” patient database for use in pharmacoepidemiological and pharmacoeconomic studies. International Journal of Clinical Pharmacology and Therapeutics 47 (2009), 617–626 (PMID:19825325).
4. Bodmer, M., Meier, C., Krähenbühl, S., Jick, S.S., Meier, C.R., Long-term metformin use is associated with decreased risk of breast cancer. Diabetes Care 33 (2010), 1304–1308, 10.2337/dc09-1791 (PMID:20299480).
5. Butler, P.C., Elashoff, M., Elashoff, R., Gale, E.A.M., A critical analysis of the clinical use of incretin-based therapies. Diabetes Care 36 (2013), 2118–2125, 10.2337/dc12-2713 (PMID:23645885).
6. Currie, C.J., Poole, C.D., Jenkins-Jones, S., Gale, E.A.M., Johnson, J.A., Morgan, C.L., Mortality after incident cancer in people with and without type 2 diabetes: Impact of metformin on survival. Diabetes Care 35 (2012), 299–304, 10.2337/dc11-1313 (PMID:22266734).
7. Elashoff, M., Matveyenko, A.V., Gier, B., Elashoff, R., Butler, P.C., Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1–based therapies. Gastroenterology 141 (2011), 150–156, 10.1053/j.gastro.2011.02.018.
8. Evans, J.M.M., Donnelly, L.A., Emslie-Smith, A.M., Alessi, D.R., Morris, A.D., Metformin and reduced risk of cancer in diabetic patients. BMJ 330 (2005), 1304–1305, 10.1136/bmj.38415.708634.F7 (PMID:15849206).
9. Goodwin, P.J., Insulin in the adjuvant breast cancer setting: A novel therapeutic target for lifestyle and pharmacologic interventions?. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 26 (2008), 833–834, 10.1200/JCO.2007.14.7132 (PMID:18281653).
10. Hagberg, K.W., Taylor, A., Hernandez, R.K., Jick, S., Incidence of bone metastases in breast cancer patients in the United Kingdom: Results of a multi-database linkage study using the general practice research database. Cancer Epidemiology 37:3 (2013), 240–246.
11. Jacob, L., Bleicher, L., Kostev, K., Kalder, M., Prevalence of depression, anxiety and their risk factors in German women with breast cancer in general and gynecological practices. Journal of Cancer Research and Clinical Oncology, 2015, 10.1007/s00432-015-2048-5 (PMID:26377737).
12. Jacob, L., Hadji, P., Albert, U.-S., Kalder, M., Kostev, K., Impact of disease management programs on women with breast cancer in Germany. Breast Cancer Research and Treatment 153 (2015), 391–395, 10.1007/s10549-015-3530-0 (PMID:26264467).
13. Jönsson, B., Wilking, N., Prevention and the economic burden of breast cancer [Internet]. 2013, GE Healthcare.
14. Kowall, B., Rathmann, W., Kostev, K., Are sulfonylurea and insulin therapies associated with a larger risk of cancer than metformin therapy? A retrospective database analysis. Diabetes Care 38:1 (2015), 59–65 (PMID:25336750).
15. Kowall, B., Stang, A., Rathmann, W., Kostev, K., No reduced risk of overall, colorectal, lung, breast, and prostate cancer with metformin therapy in diabetic patients: Database analyses from Germany and the UK. Pharmacoepidemiology and Drug Safety 24:8 (2015), 865–874 (PMID:26132313).
16. La Vecchia, C., Giordano, S.H., Hortobagyi, G.N., Chabner, B., Overweight, obesity, diabetes, and risk of breast cancer: Interlocking pieces of the puzzle. The Oncologist 16 (2011), 726–729, 10.1634/theoncologist.2011-0050 (PMID:21632448).
17. Libby, G., Donnelly, L.A., Donnan, P.T., Alessi, D.R., Morris, A.D., Evans, J.M.M., New users of metformin are at low risk of incident cancer: A cohort study among people with type 2 diabetes. Diabetes Care 32 (2009), 1620–1625, 10.2337/dc08-2175 (PMID:19564453).
18. Nechuta, S., Lu, W., Zheng, Y., Cai, H., Bao, P.-P., Gu, K.,.. Shu, X.O., Comorbidities and breast cancer survival: A report from the Shanghai Breast Cancer Survival Study. Breast Cancer Research and Treatment 139 (2013), 227–235, 10.1007/s10549-013-2521-2 (PMID:23605082).
19. Pollack, M.N., Insulin, insulin-like growth factors, insulin resistance, and neoplasia. American Journal of Clinical Nutrition 86 (2007), s820–s822 (PMID:18265475).
20. Tseng, C.-H., Lee, K.-Y., Tseng, F.-H., An updated review on cancer risk associated with incretin mimetics and enhancers. Journal of Environmental Science and Health, Part C: Environmental Carcinogenesis & Ecotoxicology Reviews 33 (2015), 67–124, 10.1080/10590501.2015.1003496 (PMID:25803196).
21. Wolf, I., Sadetzki, S., Catane, R., Karasik, A., Kaufman, B., Diabetes mellitus and breast cancer. Lancet Oncology 6 (2005), 103–111, 10.1016/S1470-2045(05)01736-5 (PMID:15683819).
22. World Cancer Research Fund International, Breast cancer statistics. http://www.wcrf.org, 2015 (accessed on 30/11/15).